Literature DB >> 27697081

Seroprevalence of Middle East Respiratory Syndrome Coronavirus Among Healthcare Personnel Caring for Patients With Middle East Respiratory Syndrome in South Korea.

Ji Yeon Lee1, Gayeon Kim2, Dong-Gyun Lim3, Hyeon-Gun Jee3, Yunyoung Jang4, Joon-Sung Joh1, Ina Jeong1, Yeonjae Kim2, Eunhee Kim4, Bum Sik Chin2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27697081      PMCID: PMC7113026          DOI: 10.1017/ice.2016.221

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


× No keyword cloud information.
The outbreak of Middle East respiratory syndrome coronavirus (MERS-CoV) in South Korea resulted in 186 infections and 36 deaths in 2015. One of the characteristics of the outbreak is that nearly all transmissions occurred in the hospitals and 39 (21.0%) of 186 confirmed cases were healthcare personnel (HCP). National Medical Center (NMC) is a 450-bed teaching hospital acting as a hub of nationwide public healthcare institutions and a total of 30 of 186 confirmed MERS-CoV patients were admitted to the NMC during the MERS-CoV outbreak from May to July in 2015. All cases were referred after the confirmation of MERS-CoV infection and were admitted to negative pressure isolation rooms. The level of personal protective equipment for HCP was determined on the basis of the expected level of contact with patients. In general, HCP wore gloves, a fluid-resistant coverall, either protective glasses or a face shield, and an N95 respirator. During aerosol-generating procedures or when caring for patients under mechanical ventilator care, HCP wore inner and outer gloves, an impermeable coverall, a powered air-purifying respirator with external belt-mounted blower, full face shield (hood), inner and outer boot covers, and an apron. During the MERS-CoV patient care period, 4 accidental exposure events among HCP were reported to the hospital authority (Table 1). Case 1 reported exposure to the blood of a patient on bare skin. Although there was no visible breakage in the exposed skin area, he was quarantined because the exposed skin area was as large as 25 cm2. Case 2 reentered the isolation room while she was doffing in the anteroom and contacted the MERS patient for approximately 5 minutes without adequate respirator protection. Case 3 accidentally entered the isolation room with a disconnected circuit of the powered air-purifying respirator for approximately 10 minutes. Case 4 experienced disconnection of the circuit of the powered air-purifying respirator during the endotracheal intubation procedure and exposure time was estimated as approximately 30 seconds. The patients to whom cases 1 and 4 were exposed presented active pneumonia with sputum positive for MERS by reverse transcription–polymerase chain reaction at the time of exposure. No data are available to determine whether the patient was viremic in case 1 (whose skin was exposed to the blood of a patient). In the other cases, pneumonia was improving and the results of sputum testing for MERS by reverse transcription–polymerase chain reaction were equivocal or negative at the moment of exposure. All of the involved HCP were quarantined for 14 days and none of them developed MERS-like symptoms.
TABLE 1

Accidental Exposure Cases During Care of Patients With MERS

Case no.OccupationSexAge, yPPEMode of exposure
1DoctorMale42N95Contact with patient’s blood on bare skin
2NurseFemale52NoneExposure to sick patient under MV without PPE for 5 min
3DoctorMale40PAPRPAPR circuit disconnect for 10 min
4DoctorMale38PAPRPAPR circuit disconnect for 30 sec

NOTE. MERS, Middle East respiratory syndrome; MV, mechanical ventilation; PAPR, powered air-purifying respirator; PPE, personal protective equipment.

Accidental Exposure Cases During Care of Patients With MERS NOTE. MERS, Middle East respiratory syndrome; MV, mechanical ventilation; PAPR, powered air-purifying respirator; PPE, personal protective equipment. To capture any subclinical infections, serosurvey was performed after the outbreak termination. Among the 333 HCPs who had participated in care of MERS patients, 285 consented to participate in the study and none revealed reactive result for MERS-CoV S1 immunoglobulin G enzyme-linked immunosorbent assay (Euroimmun) whereas 109 HCP (38.2%) reported that they experienced MERS-like symptoms during the period of care of MERS patients. HCP are one of the high-risk populations for MERS-CoV infection , and inadequate infection control measures have been reported to be responsible for the in-hospital acquisition of MERS. , Whereas symptomatic HCP were related with in-hospital superspreading events during the severe acute respiratory syndrome outbreak, a study conducted in Saudi Arabia reported that the attack rate of MERS-like symptoms was lower among the HCP who were exposed to a MERS-CoV case-patient than among the HCP without exposure (22% vs 33%) and none of them showed evidence of MERS-CoV infection. In line with that finding, only 19 (1.1%) among 1,695 HCP contacts of confirmed MERS cases tested positive in Saudi Arabia, which indicated a rather small risk of transmission to HCP. However, apparent heterogeneity exists leading to sporadic outbreaks and NMC adopted a higher infection precaution level than generally recommended, especially during aerosol-generating procedures or when caring for patients under mechanical ventilator care. Actually, 7 HCP contracted MERS at a different single institution in South Korea during the care of patients with known status of MERS infection whereas there was no seroconversion case among the 443 HCP with adequate personal protective equipment during the 2015 MERS outbreak in South Korea. In summary, there was no evidence of MERS-CoV infection among the HCP who participated in the care of 30 patients in NMC although a substantial proportion of HCP reported that they experienced MERS-like symptoms during the patient care period. Our results suggest that risk of MERS acquisition among HCP is low under stringent infection control measures.
  9 in total

1.  Control of an Outbreak of Middle East Respiratory Syndrome in a Tertiary Hospital in Korea.

Authors:  Ga Eun Park; Jae-Hoon Ko; Kyong Ran Peck; Ji Yeon Lee; Ji Yong Lee; Sun Young Cho; Young Eun Ha; Cheol-In Kang; Ji-Man Kang; Yae-Jean Kim; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Jun Haeng Lee; Ik Joon Jo; Byeong-Ho Jeong; Gee Young Suh; Jinkyeong Park; Chi Ryang Chung; Jae-Hoon Song; Doo Ryeon Chung
Journal:  Ann Intern Med       Date:  2016-05-31       Impact factor: 25.391

2.  2014 MERS-CoV outbreak in Jeddah--a link to health care facilities.

Authors:  Ikwo K Oboho; Sara M Tomczyk; Ahmad M Al-Asmari; Ayman A Banjar; Hani Al-Mugti; Muhannad S Aloraini; Khulud Z Alkhaldi; Emad L Almohammadi; Basem M Alraddadi; Susan I Gerber; David L Swerdlow; John T Watson; Tariq A Madani
Journal:  N Engl J Med       Date:  2015-02-26       Impact factor: 91.245

3.  Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, 2015.

Authors: 
Journal:  Osong Public Health Res Perspect       Date:  2015-09-05

4.  Health care worker contact with MERS patient, Saudi Arabia.

Authors:  Aron J Hall; Jerome I Tokars; Samar A Badreddine; Ziad Bin Saad; Elaine Furukawa; Malak Al Masri; Lia M Haynes; Susan I Gerber; David T Kuhar; Congrong Miao; Suvang U Trivedi; Mark A Pallansch; Rana Hajjeh; Ziad A Memish
Journal:  Emerg Infect Dis       Date:  2014-12       Impact factor: 6.883

5.  Infection control and MERS-CoV in health-care workers.

Authors:  Alimuddin Zumla; David S Hui
Journal:  Lancet       Date:  2014-05-20       Impact factor: 79.321

6.  Surveillance of the Middle East respiratory syndrome (MERS) coronavirus (CoV) infection in healthcare workers after contact with confirmed MERS patients: incidence and risk factors of MERS-CoV seropositivity.

Authors:  C-J Kim; W S Choi; Y Jung; S Kiem; H Y Seol; H J Woo; Y H Choi; J S Son; K-H Kim; Y-S Kim; E S Kim; S H Park; J H Yoon; S-M Choi; H Lee; W S Oh; S-Y Choi; N-J Kim; J-P Choi; S Y Park; J Kim; S J Jeong; K S Lee; H C Jang; J Y Rhee; B-N Kim; J H Bang; J H Lee; S Park; H Y Kim; J K Choi; Y-M Wi; H J Choi
Journal:  Clin Microbiol Infect       Date:  2016-07-27       Impact factor: 8.067

7.  Comparative Epidemiology of Human Infections with Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome Coronaviruses among Healthcare Personnel.

Authors:  Shelan Liu; Ta-Chien Chan; Yu-Tseng Chu; Joseph Tsung-Shu Wu; Xingyi Geng; Na Zhao; Wei Cheng; Enfu Chen; Chwan-Chuen King
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

8.  Why did outbreaks of severe acute respiratory syndrome occur in some hospital wards but not in others?

Authors:  Ignatius T Yu; Zhan Hong Xie; Kelvin K Tsoi; Yuk Lan Chiu; Siu Wai Lok; Xiao Ping Tang; David S Hui; Nelson Lee; Yi Min Li; Zhi Tong Huang; Tao Liu; Tze Wai Wong; Nan Shan Zhong; Joseph J Sung
Journal:  Clin Infect Dis       Date:  2007-03-09       Impact factor: 9.079

9.  Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study.

Authors:  Z A Memish; J A Al-Tawfiq; H Q Makhdoom; A A Al-Rabeeah; A Assiri; R F Alhakeem; F A AlRabiah; S Al Hajjar; A Albarrak; H Flemban; H Balkhy; M Barry; S Alhassan; S Alsubaie; A Zumla
Journal:  Clin Microbiol Infect       Date:  2014-02-17       Impact factor: 8.067

  9 in total
  2 in total

Review 1.  Middle East respiratory syndrome: what we learned from the 2015 outbreak in the Republic of Korea.

Authors:  Myoung-Don Oh; Wan Beom Park; Sang-Won Park; Pyoeng Gyun Choe; Ji Hwan Bang; Kyoung-Ho Song; Eu Suk Kim; Hong Bin Kim; Nam Joong Kim
Journal:  Korean J Intern Med       Date:  2018-02-27       Impact factor: 2.884

2.  A Middle East respiratory syndrome screening clinic for health care personnel during the 2015 Middle East respiratory syndrome outbreak in South Korea: A single-center experience.

Authors:  Ji Yeon Lee; Gayeon Kim; Dong-Gyun Lim; Hyeon-Gun Jee; Yunyoung Jang; Joon-Sung Joh; Ina Jeong; Yeonjae Kim; Eunhee Kim; Bum Sik Chin
Journal:  Am J Infect Control       Date:  2017-11-16       Impact factor: 2.918

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.